RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Pierre Fabre Medicament
Pierre Fabre Medicament S a s
  

Pierre Fabre Medicament patents

Recent patent applications related to Pierre Fabre Medicament. Pierre Fabre Medicament is listed as an Agent/Assignee. Note: Pierre Fabre Medicament may have other listings under different names/spellings. We're not affiliated with Pierre Fabre Medicament, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pierre Fabre Medicament-related inventors




Date Pierre Fabre Medicament patents (updated weekly) - BOOKMARK this page
05/18/17Flavagline derivatives
04/27/17Conjugate of monomethyl auristatin f and trastuzumab and its use for the treatment of cancer
03/09/17Aminocyclobutane derivatives, preparing same and the use thereof as drugs
02/16/17Igf-1r antibody-drug-conjugate and its use for the treatment of cancer
02/16/17Antibody-drug-conjugate and its use for the treatment of cancer
11/10/16Novel anti adam17 antibody and its use for the treatment of cancer
10/20/16Chromone derivative as a dopamine d3 receptor antagonist for its use for the treatment of autism spectrum disorder
10/06/16Medicinal lozenge based on ibuprofen sodium dihydrate
10/06/16Use of par-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions
10/06/16Griseofulvin derivatives
08/25/16Obtaining a juice of fresh plants by thermomechanical treatment and cosmetic and therapeutic use thereof
08/11/16Quinazoline derivatives and their use as dna methyltransferase inhibitors
06/09/16Anti-cmet antibody
05/26/16Method for producing triptolide
05/12/16Novel antigen binding protein and its use as addressing product for the treatment of cancer
04/21/16Axl antibody-drug conjugate and its use for the treatment of cancer
03/24/16Composition comprising a combination of an elder extract and a strain of lactobacillus rhamnosus
03/24/16Derivatives of dolastatin 10 and auristatins
03/10/16Derivatives of dolastatin 10 and auristatins
03/10/16Derivatives of dolastatin 10 and auristatins
02/18/16Novel antigen binding proteins and their use as addressing product for the treatment of cancer
02/11/16Novel anti-cmet antibody
02/04/16Novel antibodies for the treatment of hiv
12/31/15Macrolides useful as anticancer agents
12/24/15(poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents
11/26/15Novel benzodioxane-piperidine derivatives and their therapeutic applications for treating neuropsychiatric disorders
11/05/15Combination of a slow sodium current blocker and a sinus if current inhibitor, and the pharmaceutical compositions containing said combination
11/05/15Aminocyclobutane derivatives, preparing same and the use thereof as drugs
10/29/15Use of a dha ester for prophylactic and/or curative treatment of drepanocytosis
10/29/15Novel anti-cmet antibody
10/15/15Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases
10/15/15Anti-cmet antibody
09/24/15Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk
09/10/15Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
09/10/15Novel antibodies inhibiting c-met dimerization and uses thereof
09/10/15Novel antibodies inhibiting c-met dimerization and uses thereof
08/27/15Process for the modulation of the antagonistic activity of a monoclonal antibody
07/30/15Griseofulvin derivatives
07/09/15Derivatives of azaindazole or diazaindazole type for treating pain
07/09/15Griseofulvin derivatives
06/11/15Lozenges with multiple release kinetics for active ingredients
03/19/15Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
02/12/15Transdermal device including porous microparticles
02/05/15Novel antigen binding protein and its use as addressing product for the treatment of cancer
10/02/14Anti-cmet antibody and its use for the detection and the diagnosis of cancer
08/21/14Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for preventing and/or treating cardiotoxic effects caused by chemotherapy and/or radiation
07/24/14Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases
07/10/14Anti-cd151 antibodies and their use in the treatment of cancer
07/03/14Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
06/26/14Levomilnacipran-based drug for functional recovery after acute neurological events
06/19/14Use of the antibody i-3859 for the detection and diagnosis of cancer
05/22/14Novel antigen binding protein and its use as addressing product for the treatment of cancer
04/24/14Novel anti-cmet antibody
02/20/14Novel anti-cxcr4 antibodies and their use for the treatment of cancer
02/06/14Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
01/30/14Tri - and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
01/09/14Novel antibodies inhibiting c-met dimerization and uses thereof
01/09/14Method for correcting immunopathological reactions and a medicament
11/28/13Inclusion complexes containing piroxicam, a cyclodextrin and arginine
11/14/13Novel homogeneous humanized antiproliferation antibodies
11/07/13Vinyl quinuclidine useful as a synthesis intermediate in the preparation of (r)-mequitazine
10/17/13Novel antibodies inhibiting c-met dimerization, and uses thereof
10/17/13Novel antibodies inhibiting c-met dimerization, and uses thereof
10/10/13Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans
07/18/13Fluorescent cyanine-polyamine derivatives as a diagnostic probe
Patent Packs
07/04/13Technetium-99m complex as a tool for the in vivo diagnosis of cancerous tumours
07/04/13Method for the preparation of sodium chondroitin sulphate
07/04/13Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
07/04/13Derivatives of azaindazole or diazaindazole type as medicament
05/30/13Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases
05/16/13Novel anti-igf-ir antibodies and uses thereof
05/02/13Process for the modulation of the antagonistic activity of a monoclonal antibody
05/02/13Anti-cmet antibody
05/02/13Anti-cmet antibody
05/02/13Anti-cmet antibody
04/04/13Derivatives of azaindazole or diazaindazole type as medicament
02/14/13Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics
12/20/12Novel phage display vector
11/08/12Anti-cd151 antibodies and their use in the treatment of cancer
09/27/12Pyrazolopyridine derivatives as anticancer agent
Patent Packs
09/06/12Method for producing triptolide
08/30/12Use of an anti-cd151 antibody in the treatment of cancer
08/16/12Novel anti-igf-ir and/or anti-insulin/igf-i hybrid receptors antibodies and uses thereof
07/12/12Microplate
07/12/12Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
06/21/12Anti-jam-a antibodies
06/21/12Chromone derivatives, a process for their preparation and their therapeutic applications
06/07/12Pharmaceutical composition including a dha ester to be administered parenterally
05/10/12Novel derivatives of aryl--methanone, their preparation and their use as medicinal products
04/12/12Pyridin-2-yl methylamine derivatives for treating opiate dependence
03/29/12Ngcycloartanone derivatives with anticancer activity
03/15/12Method for impregnation with supercritical co2
02/02/12Derivatives of aminocyclobutane or aminocyclobutene, their preparation and their use as medical products
01/26/12Process for the preparation of (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin useful for their applications in therapeutics as anticancer agent
12/29/11Derivatives of benzothiazines, preparation thereof and application thereof as drugs
12/01/11Novel anti cxcr4 antibodies and their use for the treatment of cancer
12/01/11Method for synthesis of (1s, 2r)-milnacipran
11/24/11Novel anti cxcr4 antibodies and their use for the treatment of cancer
10/27/11Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus
07/28/11Novel anti-igf-ir antibodies and uses thereof
07/07/11Use of an anti-cd151 antibody for early treatment of cancer
05/26/11Nitrogenated derivatives of pancratistatin
05/19/11Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
05/19/11Derivatives of triazines and uracils, their preparation and their application in human therapeutics
01/27/11Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
01/20/11Novel anti-igf-ir and/or anti-insulin/igf-i hybrid receptors antibodies and uses thereof
01/20/11Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
01/06/11Novel generating and screening an antibody library
11/11/105-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphthalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde as medicaments
11/04/10Process for the synthesis of anticancer (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin
Social Network Patent Pack
10/28/10Mequitazine for treating or preventing pathologies involving histamine h4 receptors
08/12/10Novel fluorescent derivatives of polyamines, preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumors
08/05/10Stable pharmaceutical composition of a water-soluble vinorelbine salt
08/05/10Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
06/17/10Use of an anti-cxcr4 antibody in the treatment of cancer
06/10/10Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
04/29/10Novel quinuclidine derivative useful in the preparation of mequitazine
04/22/10Pyridin-2-yl-methylamine derivatives for treating opiate dependence
04/15/10Novel anti-proliferation antibodies
04/08/10Complexes of ibuprofen, cyclodextrins and ternary agents and the use thereof in pharmaceutics
Patent Packs
04/08/10Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature
03/11/10Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2, and m3 receptors
02/18/10Rapid disintegration monolayer film for the oral administration of active substances
02/04/10Anhydrous crystalline vinflunine salts, preparation and use thereof as a drug and means of vinflunine purification
12/31/09Use of an anti-cd151 antibody in the treatment of cancer
12/31/09Eucalyptus extract, preparation and therapeutic uses thereof
12/24/09Treatment of vertigo with acetyl-l-leucine
12/24/09Process for the synthesis of n-[3-[(2-methoxyphenyl] sulfanyl] -2-methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine.
12/17/09Dha esters and use thereof in treatment and prevention of cardiovascular disease
12/03/09Dmae as sole agent for the treatment of mild cognitive impairment
10/22/09Novel anti-igf-ir antibodies and uses thereof
07/16/09Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
05/07/09Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4--piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives
03/26/09Pharmaceutical compositions containing omega 3 fatty acids
03/26/09Process for preparing [2-(2,3- dihydrobenzofuran - or benzofuran-7-yloxy)ethyl]-(3 -cyclopent-1-ylbenzyl)amine derivatives and synthesis intermediate
03/12/09Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses
02/26/09Stabilized milnacipran formulation
02/05/09Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
12/10/15Composition comprising an encapsulated antagomir







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pierre Fabre Medicament in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pierre Fabre Medicament with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';